Form 4: ReposiTrak CEO Sells Shares Under Pre-Arranged Charitable Trading Plan
Insider Transaction Report
ReposiTrak, Inc. CEO and 10% owner Randall K. Fields reported the sale of 7,500 shares of common stock through a Rule 10b5-1 trading plan for charitable commitments.
Summary
- Randall K. Fields, Chief Executive Officer, Director, and 10% Owner of ReposiTrak, Inc. (TRAK), reported changes in his beneficial ownership.
- On June 30, 2025, 2,626 shares of common stock were sold indirectly by RK Fields Charitable 2022, LLC at a weighted average price of $20.0089 per share.
- On July 01, 2025, an additional 4,874 shares of common stock were sold indirectly by RK Fields Charitable 2022, LLC at a weighted average price of $19.4508 per share.
- The total number of common shares sold across both transactions was 7,500.
- These sales were executed automatically pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
- The trading plan was established to enable Mr. Fields to meet some of his charitable commitments.
- Following these transactions, Mr. Fields beneficially owns 3,683,955 shares of common stock directly, and indirectly owns 154,500 shares of common stock through RK Fields Charitable 2022, LLC, 615,260 shares of common stock through Riverview Financial Corp., 30,667 shares of common stock through his Spouse, and 333,643 shares of common stock through Fields Management, Inc.
- He also indirectly owns 531,432 shares of Series B Preferred Stock through Riverview Financial Corp. and 12,322 shares of Series B Preferred Stock through his Spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that it was conducted under a pre-arranged 10b5-1 plan for charitable purposes mitigates concerns about its implications for the company's future performance.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not a reaction to recent negative company developments.
- The stated purpose of the sales is to meet charitable commitments, which can be viewed positively as a philanthropic endeavor.
Negatives
- Insider selling, even if pre-planned, can sometimes be perceived negatively by the market, potentially signaling a lack of confidence or a desire for liquidity by a key executive.
- The sales represent a reduction in the CEO's indirect common stock holdings, albeit a small percentage of his total beneficial ownership.
Risks
- No specific risks are detailed in this Form 4 filing beyond the general market perception of insider selling.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
- The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments.
Industry Context
This Form 4 filing is specific to ReposiTrak, Inc. and its CEO's personal stock transactions. It does not provide information directly related to broader industry trends or competitive landscape.
Related Party Transactions
- The sales of common stock were executed by RK Fields Charitable 2022, LLC, an entity indirectly controlled by Randall K. Fields, the CEO, Director, and 10% Owner of ReposiTrak, Inc. This constitutes a transaction involving a related party.
Stakeholder Impact
- Shareholders may observe the insider selling, which could lead to varied interpretations regarding management's confidence or liquidity needs. However, the 10b5-1 plan and charitable purpose provide context that may alleviate negative perceptions.
Next Steps
- The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported ranges.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Transaction date for the sale of 2,626 common shares by RK Fields Charitable 2022, LLC. |
| 07/01/2025 | Transaction date for the sale of 4,874 common shares by RK Fields Charitable 2022, LLC. |
| 07/02/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdKeywords
ReposiTrak, TRAK, Form 4, insider trading, stock sale, CEO, Randall K. Fields, 10b5-1 plan, beneficial ownership, common stock, charitable commitments
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.